An excellent combination of scientifically proven implant technology and sleek prosthetic components.

1 2

The new Straumann® Bone Level Tapered Implant

The new Straumann® Bone Level Tapered Implant provides an optimized choice for implant treatment. It provides a unique combination of mechanics and biology for ease of use and enhanced primary stability. The unique Roxolid® material has been specifically designed for dental implantology and delivers outstanding mechanical results. Combined with the SLActive® surface, Straumann delivers an excellent implant system with outstanding osseointegration and healing properties.

The new Straumann® Screw-retained Abutment provides a wide range of prosthetic options for screw-retained restorations. A low abutment profile as well as various angulations and gingiva heights offer you flexibility to provide an individual solution for edentulous patients, including restoring posterior-tilted implants.26

Roxolid®

Reducing invasiveness with smaller implants

  • More treatment options with smaller implants
  • Preserves bone and reduces invasive grafting procedures1,2
  • Increased patient acceptance with less invasive procedures27

SLActive®

Designed to maximize your treatment success and predictability

  • Higher treatment predictability in challenging protocols1,3-7
  • Broadens treatment potentials for all your patients8-15
  • Safer and faster treatment in 3-4 weeks for all indications16-25

Apically tapered

Excellent primary stability even in compromised bone situations

  • Full-depth thread to apex for early engagement
  • Self-cutting in underprepared sites
  • Protecting anatomical structure with round tip

References

1 Benic GI, Gallucci GO, Mokti M, Hämmerle CH, Weber HP, Jung RE. Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study. Journal of Clinical Periodontology 2013; [Epub ahead of print] 2 Nicolau P et al.: Immediate and early loading of chronically modified implants in posterior jaws: 3-year results from a prospective randomized study. Clin Implant Dent Relat Res. 2013 Aug;15(4):600-612 3 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive®) and conventional SLA® titanium implants: a pilot study in dogs. J Clin.Periodontol. 34.1 (2007): 78–86 4 Lai HC, Zhuang LF, Zhang ZY, Wieland M, Liu X. Bone apposition around two different sandblasted, large-grit and acid-etched implant surfaces at sites with coronal circumferential defects: An experimental study in dogs. Clin. Oral Impl. Res. 2009;20(3):247–53 5 Buser D, Wittneben J, Bornstein MM, Grütter L, Chappuis V, Belser UC. Stability of Contour Augmentation and Esthetic Outcomes of Implant-Supported Single Crowns in the Esthetic Zone: 3-Year Result of a Prospective Study With Early Implant Placement Post Extraction. J Periodontol. 2011 March; 82(3): 342-9 6 Buser D, Chappuis V, Kuchler U, Bornstein MM, Wittneben JG, Buser R, Cavusoglu Y, Belser UC. Long-term Stability of Early Implant Placement with Contour Augmentation. J Dent Res. 2013 Dec;92(12 Suppl):176S-82S 7 Nicolau P, Reis R, Guerra F, Rocha S, Tondela J, Brägger U. Immediate and early loading of Straumann® SLActive implants: A Five Year Follow-up. Presented at the 19th Annual Scientific Meeting of the European Association of Osseointegration – 6-9 October 2010, Glasgow 8 International Diabetes Federation. http://www.idf.org/diabetesatlas/ 9 Schlegel KA, Prechtl C, Möst T, Seidl C, Lutz R, von Wilmowsky C. Osseointegration of SLActive® implants in diabetic pigs Clin Oral Implants Res. 2013 Feb;24 (2):128-34 10 Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006 Feb;38(2 Suppl 1):S4-9 11 Mardas N, Schwarz F, Petrie A, Hakimi AR, Donos N. The effect of SLActive® surface in guided bone formation in osteoporotic-like conditions Clin Oral Implants Res. 2011 Apr;22(4):406-15 12 WHO: http://www.who.int/ageing/about/facts/en/index.html 13 iData Report , Dental Implants and Final Abutments, Europe 2012 14 iData Report , Dental Implants and Final Abutments, USA 2012 15 Slotte Christer et al, Four-mm implants supporting fixed partial dentures in the posterior mandible. 5-year results from a multicenter study. Presented at the 20th Annual Scientific Meeting of the European Association of Osseointegration, 10-13 October 2012, Copenhagen, Denmark 16 from single-tooth to edentulous 17 Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. Journal of Biomedical Materials Research A, 76(2):323-334, 2006 18 De Wild M. Superhydrophilic SLActive® implants. Straumann document 151.52, 2005 19 Katharina Maniura. Laboratory for Materials – Biology Interactions Empa, St. Gallen, Switzerland Protein and blood adsorption on Ti and TiZr implants as a model for osseointegration. EAO 22nd Annual Scientific Meeting, October 17 – 19 2013, Dublin 20 Schwarz, F., et al., Bone regeneration in dehiscence-type defects at non-submerged and submerged chemically modified (SLActive®) and conventional SLA® titanium implants: an immunohistochemical study in dogs. J Clin.Periodontol. 35.1 (2008): 64–75 21 Rausch-fan X, Qu Z, Wieland M, Matejka M, Schedle A. Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces. Dental Materials 2008 Jan;24(1):102-10. Epub 2007 Apr 27 22 Schwarz F, Herten M, Sager M, Wieland M, Dard M, Becker J. Histological and immunohistochemical analysis of initial and early osseous integration at chemically modified and conventional SLA® titanium implants: Preliminary results of a pilot study in dogs. Clinical Oral Implants Research, 11(4): 481-488, 2007 23 Lang, N.P., et al., Early osseointegration to hydrophilic and hydrophobic implant surfaces in humans. Clin Oral Implants.Res 22.4 (2011): 349–56 24 Raghavendra S, Wood MC, Taylor TD. Int. J. Oral Maxillofac. Implants. 2005 May–Jun;20(3):425–31 25 Oates TW, Valderrama P, Bischof M, Nedir R, Jones A, Simpson J, Toutenburg H, Cochran DL. Enhanced implant stability with a chemically modified SLA® surface: a randomized pilot study. Int. J. Oral Maxillofac. Implants. 2007;22(5):755–760 26 Compared to existing Straumann® Multi-base portfolio 27 if a GBR procedure can be avoided


Straumann® Screw-retained Abutment

  • Same connector design for all diameters allows for a streamlined portfolio of tertiary components
  • Abutment angulations of 17° and 30°
  • Different gingiva heights of 1 mm, 2.5 mm, 4 mm and 5.5 mm
  • Simplified handling with CrossFit® connection

Straumann® CARES® Screw-retained Bars and Bridges

  • Custom-milled frameworks for final restoration
  • Multiple bar and bridge designs available
  • Bars and bridges for abutment level or implant level
  • Also available in 3M™ Espe™ Lava™ Plus zirconia material